Signos announced today that it launched its FDA-cleared over-the-counter glucose monitoring system for weight management.

Any patient can access Signos' system, which uses an AI platform and an off-the-shelf continuous glucose monitor, or CGM, ...

Insiders tell CNN the FDA’s AI is “hallucinating” studies and can’t access key documents. Agency leaders insist the AI is ...

The ArteraAI prostate test uses artificial intelligence and biomarkers to predict if standard hormone therapy will be ...

The FDA’s De Novo authorization for the tool establishes a new product code category for future AI-powered digital pathology risk-stratification tools.

The approval of ArteraAI Prostate by the FDA as a software as a medical device (SaMD) means it can now be used at the point ...

The FDA’s AI program needs to have guardrails in place to ensure it’s working properly. No matter what AI is used for at the FDA, processes must be in place to ensure fairness and accuracy ...

In a series of tweets in April, FDA Commissioner Scott Gottlieb, MD, wrote the agency is working toward a new regulatory approach to promote the use of AI algorithms that diagnose and treat diseases.

Digital transformation in healthcare accelerates adoption of AI-enabled monitoring solutions across global marketsDelray ...

Precigen, Inc. (NASDAQ:PGEN) is one of the best multibagger penny stocks to buy according to analysts. On August 15, the ...